Arkolith/Insider Trading/ADAP/Form 4

Lunger John

Chief Patient Supply OfficerAdaptimmune Therapeutics PLC (ADAP) · full profile →Form 4 · filed Jan 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 17, 2024Sell(S)5K$0.67$4K8K
Jan 17, 2024Sell(S)13K$0.67$9K19K
Jan 16, 2024Sell(S)5K$0.79$4K7K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-004562) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML